CLOs on the Move

Merlin Development Inc

www.merlindev.com

 
Merlin Development Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.merlindev.com
  • 181 Cheshire Ln N Ste 500
    Minneapolis, MN USA 55441
  • Phone: 763.475.0224

Executives

Name Title Contact Details

Similar Companies

Martab Physicians Hospital Supply Co.

Martab Physicians Hospital Supply Co. is a Mahwah, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beekley

Founded in 1934, Beekley Corporation has evolved into the world leading supplier of simple innovative medical products that help imaging, surgical, and radiation therapy professionals save time, improve accuracy, enhance communication and provide a better patient experience.   Beekley introduced the X-SPOT, the first ever professional skin marker for diagnostic imaging in 1984. The X-SPOT® replaced a variety of makeshift methods used at the time for communicating an area of concern on film. It quickly became a staple in radiology departments across the country and its quick adaptation in all radiology modalities led Beekley to devote itself to the research and development of simple, low cost, disposable products that would help imaging professionals improve communication, productivity, and patient care.   Today, Beekley`s product line has grown to include a broad range of radiologic skin markers, biopsy and patient care devices for Mammography; Breast Biopsy; Radiation Therapy; MRI; CT-Scan and General Radiology.

Caption Health

Caption Health was founded in 2013 on a simple but powerful concept: what if we could use technology to emulate the expertise of highly trained medical experts and put that ability into the hands of every care provider?

Agde

Agde Corp. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sight Sciences

Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.